is an autism spectrum disorder (ASD) risk gene and encodes a voltage-gated sodium channel. However, the impact of ASD-associated SCN2A variants on human neuron development is unknown. We studied SCN2A using isogenic induced pluripotent stem cells (iPSCs), and patient-derived iPSCs harboring a R607* truncating variant. We used Neurogenin2 to generate excitatory (glutamatergic) neurons and found that and neurons displayed a reduction in synapse formation and excitatory synaptic activity. We found differential impact on actional potential dynamics and neuronal excitability that reveals a loss-of-function effect of the R607* variant. Our study reveals that a truncating variant impairs the development of human neuronal function.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10824931PMC
http://dx.doi.org/10.3389/fncel.2023.1239069DOI Listing

Publication Analysis

Top Keywords

truncating variant
8
disruption autism-associated
4
autism-associated gene
4
gene alters
4
alters synaptic
4
synaptic development
4
development neuronal
4
neuronal signaling
4
signaling patient
4
patient ipsc-glutamatergic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!